Axe Compute (AGPU)
Provides enterprise GPU capacity through distributed access and customer-specific owned clusters.
Something off on this page? Send us feedback.
Provides enterprise GPU capacity through a third-party Access model and an owned-and-operated Build model, with revenue from reserved capacity and long-term service arrangements. Its treasury and Access supply are concentrated in the Aethir network and ATH token.
Offers two enterprise GPU-infrastructure paths: Axe Compute Access coordinates available third-party capacity, while Axe Compute Build designs, deploys, owns, and operates dedicated customer clusters. Access supports hardware, location, and deployment choices; revenue is structured around reserved capacity and related compute services.
Maintains an ATH treasury strategy tied to the Aethir decentralized GPU network, and its Access model sources infrastructure primarily through that network. Build execution depends on hardware supply, data-center sites, power, customer prepayments, financing, and service commencement.
Retains Helomics drug-discovery services, which use a tumor biobank and three-dimensional culture models, while the board reviews strategic alternatives for that legacy business. Future compute revenue is expected to be concentrated in a limited number of customers and contracts.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $21.9M · Total debt $1.7M · Total assets $100.4M · Shareholders' equity $34.0M
- Revenue
- $3.2M
- Operating income
- −$4.2M
- Net income
- −$17.2M
No dividends on record.
| Insiders11 holders · as of May 29, 2026 | 3.07% | 355.8K shares | |
| Otherremainder | 96.93% | 11.24M shares |
11.59M company shares as of Sep 3, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Kyle Robert OkamotoInsiderofficer: President | 2.11% | 244,389 | Form 4filed Apr 2, 2026 ↗ |
Charles Lee Sr NuzumInsiderdirector | 0.18% | 20,388 | Form 4filed Apr 23, 2026 ↗ |
Theodore ZhuInsiderdirector | 0.17% | 20,144 | Form 4filed May 29, 2026 ↗ |
Raymond F. VennareInsiderdirector, officer: Chief Executive Officer | 0.17% | 19,677 | Form 4filed Feb 9, 2026 ↗ |
Clair Gregory Sr St.Insiderdirector | 0.13% | 15,146 | Form 4filed Apr 22, 2026 ↗ |
| See all 11 → | |||
Form 4 — an insider's transaction report
Insider tradesForm 4
No open-market trades in the last 12 months.
- CoreWeave
Direct GPU-cloud and AI-factory rival for enterprise capacity.
- Nebius
Independent AI cloud provider for large-scale GPU clusters.
- Amazon
Hyperscale alternative for GPU cloud and reserved AI capacity.
- Champions Oncology
Direct oncology CRO rival in translational drug-discovery services.
- Microsoft
Hyperscale GPU-cloud alternative for enterprise AI deployments.
- Alphabet Class A
Hyperscale GPU-cloud alternative with global AI infrastructure.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Axe Compute | $9.81 | +3.81% | $112.5M | — | — | 34.5 | +119,772.9% |
| CoreWeave | $80.50 | −0.52% | $44.15B | — | — | 5.8 | +112.3% |
| Nebius | $202.42 | −0.87% | $48.98B | — | — | 36.1 | +454.0% |
| Amazon | $255.73 | +0.31% | $2.74T | 20.5 | 27.3 | 3.5 | +19.6% |
| Champions Oncology | $5.15 | +3.00% | $71.6M | — | 51.5 | 1.2 | +12.0% |
| Microsoft | $498.16 | +0.27% | $3.69T | 27.7 | 25.4 | 11.1 | +17.8% |
| Alphabet Class A | $338.36 | +0.36% | $4.08T | 16.9 | 25.1 | 9.2 | +24.2% |
| Median | 20.5 | 26.3 | 7.5 | +21.9% |